Literature DB >> 12953814

Specific autoantibodies to platelet glycoproteins in Epstein-Barr virus-associated immune thrombocytopenia.

Miyuki Tanaka1, Takehiko Kamijo, Kenichi Koike, Ichiro Ueno, Yozo Nakazawa, Yumi Kurokawa, Kazuo Sakashita, Atsushi Komiyama, Koji Fujisawa.   

Abstract

In this study, we detected autoantibodies to platelet glycoproteins GPIIb/IIIa and GPIb/IX on platelets and in plasma in a patient with immune thrombocytopenia associated with Epstein-Barr virus-related infectious mononucleosis. In addition, we present our findings on the effectiveness of intravenous immunoglobulin therapy for immune thrombocytopenia associated with Epstein-Barr virus.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12953814     DOI： 10.1007/BF02983388

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  12 in total

1.  Workshop on autoimmune (idiopathic) thrombocytopenic purpura: pathogenesis and new approaches to therapy.

Authors:  R H Aster; J N George; R McMillan; P Ganguly
Journal:  Am J Hematol       Date:  1998-07       Impact factor: 10.047

2.  Platelet autoantibody in a case of infectious mononucleosis presenting as thrombocytopenic purpura.

Authors:  L Ellman; A Carvalho; B M Jacobson; R W Colman
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

Review 3.  Virus-associated idiopathic thrombocytopenic purpura.

Authors:  M L Rand; J F Wright
Journal:  Transfus Sci       Date:  1998-09

Review 4.  Infection-induced thrombocytopenia.

Authors:  J J Wilson; P B Neame; J G Kelton
Journal:  Semin Thromb Hemost       Date:  1982-07       Impact factor: 4.180

5.  International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies.

Authors:  P Berchtold; D Müller; D Beardsley; K Fujisawa; C Kaplan; R Kekomäki; E Lipp; M C Morell-Kopp; V Kiefel; R McMillan; A E von dem Borne; P Imbach
Journal:  Br J Haematol       Date:  1997-03       Impact factor: 6.998

6.  Epstein-Barr virus infectious mononucleosis in children. I. Clinical and general laboratory findings.

Authors:  C V Sumaya; Y Ench
Journal:  Pediatrics       Date:  1985-06       Impact factor: 7.124

7.  A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.

Authors:  K Fujisawa; H Iyori; H Ohkawa; S Konishi; F Bessho; A Shirahata; S Miyazaki; J Akatsuka
Journal:  Int J Hematol       Date:  2000-10       Impact factor: 2.490

8.  Different specificities of platelet-associated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic immune thrombocytopenic purpura.

Authors:  K Fujisawa; P Tani; T E O'Toole; M H Ginsberg; R McMillan
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

9.  Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP.

Authors:  R McMillan; P Tani; F Millard; P Berchtold; L Renshaw; V L Woods
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

10.  Antibodies to platelet membrane glycoprotein antigens in three cases of infectious mononucleosis-induced thrombocytopenic purpura.

Authors:  J Winiarski
Journal:  Eur J Haematol       Date:  1989-07       Impact factor: 2.997
View more
  7 in total

1.  Severe thrombocytopenia and recurrent epistaxis associated with primary Epstein-Barr virus infection.

Authors:  William Tilden; Shahnawaz Valliani
Journal:  BMJ Case Rep       Date:  2015-04-09

2.  Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

Authors:  Michael L Freeman; Claire E Burkum; Kathleen G Lanzer; Alan D Roberts; Mykola Pinkevych; Asako Itakura; Lawrence W Kummer; Frank M Szaba; Miles P Davenport; Owen J T McCarty; David L Woodland; Stephen T Smiley; Marcia A Blackman
Journal:  J Autoimmun       Date:  2012-12-14       Impact factor: 7.094

Review 3.  Review: Viral infections and mechanisms of thrombosis and bleeding.

Authors:  M Goeijenbier; M van Wissen; C van de Weg; E Jong; V E A Gerdes; J C M Meijers; D P M Brandjes; E C M van Gorp
Journal:  J Med Virol       Date:  2012-10       Impact factor: 2.327

4.  Prevalence of Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Subclinical Infection in Patients with Acute Immune Thrombocytopenic Purpura (ITP).

Authors:  Farshad Abbasi; Gholam Abbas Kaydani; Zari Tahannezhad; Mohsen Nakhaie; Ali Amin Asnafi; Maryam Moradi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2021-07-01

5.  Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura.

Authors:  Mana Nishikawa; Noriaki Shimada; Tomohiro Kawazoe; Ryo Sawaki; Haruka Ikuta; Motoko Kanzaki; Kosuke Fukuoka; Masaki Fukushima; Kenichiro Asano
Journal:  Intern Med       Date:  2019-12-20       Impact factor: 1.271

6.  Human metapneumovirus infection in an immunocompetent adult presenting as mononucleosis-like illness.

Authors:  Iris W S Li; Kelvin K W To; Bone S F Tang; Kwok-Hung Chan; Chee-Kin Hui; Vincent C C Cheng; Kwok-Yung Yuen
Journal:  J Infect       Date:  2008-04-18       Impact factor: 6.072

7.  Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.

Authors:  Matthieu Mahévas; Guillaume Moulis; Emmanuel Andres; Etienne Riviere; Margaux Garzaro; Etienne Crickx; Vivien Guillotin; Marion Malphettes; Lionel Galicier; Nicolas Noel; Luc Darnige; Louis Terriou; Claire Guerveno; Mateo Sanchis-Borja; Thomas Moulinet; Benoit Meunier; Mikael Ebbo; Marc Michel; Bertrand Godeau
Journal:  Br J Haematol       Date:  2020-08-04       Impact factor: 8.615
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.